Insider Transactions in Q1 2022 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 30
2022
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,254
-1.76%
|
$101,016
$4.74 P/Share
|
Mar 30
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
33,686
-2.29%
|
$134,744
$4.84 P/Share
|
Mar 30
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-1.28%
|
$8,308
$4.74 P/Share
|
Mar 30
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,486
-1.51%
|
$9,944
$4.84 P/Share
|
Mar 30
2022
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,092
-1.17%
|
$60,368
$4.74 P/Share
|
Mar 30
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
19,336
-1.48%
|
$77,344
$4.84 P/Share
|
Mar 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,281
-4.23%
|
$36,405
$5.06 P/Share
|
Mar 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
35,386
-2.35%
|
$176,930
$5.06 P/Share
|
Mar 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
80,045
-5.76%
|
$400,225
$5.06 P/Share
|
Mar 18
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
82,006
-5.16%
|
$410,030
$5.13 P/Share
|
Mar 18
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,153
-1.23%
|
$10,765
$5.13 P/Share
|
Mar 07
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
92,324
-5.49%
|
$461,620
$5.52 P/Share
|
Mar 07
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,091
-1.74%
|
$15,455
$5.52 P/Share
|